Supreme Court considers restrictions on mifepristone in abortion cases.
An anti-abortion coalition is urging the Supreme Court to uphold a lower court decision that would prevent patients from obtaining the abortion pill mifepristone by mail. The coalition argues that the FDA has stripped away necessary safeguards on chemical abortion, while the government warns of regulatory chaos if the lower court ruling goes into effect. The Supreme Court, which has a conservative majority, is set to act by midnight on Wednesday. The case raises different legal issues about the FDA’s process for approving drugs and will test the court’s pledge last year to leave abortion policy to the states and federal government.